Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ANDG vs HTFL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HTFL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–2 Matrix Metrics)

HTFL Overall Winner 6-Pillar Tally: ANDG 0 – 5 HTFL (1 Tie) Matrix Metrics: ANDG 2 – 7 HTFL

As of Nov 20, 2026, Heartflow, Inc. (HTFL) is the stronger overall head-to-head candidate over ANDG (ANDG) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ANDG carries a Unified Composite Score of 56.7/100 (HOLD) at $57.85 (N/M Forward P/E, N/A operating margin), whereas HTFL carries 64.2/100 (BUY) at $46.69 (N/M Forward P/E, -30.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ANDG vs HTFL
ANDG US Equity
ANDG
Institutional Equity
$57.85
+0.4% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.45β · 44% Vol
Unified Composite Score
56.7 / 100 HOLD
Tech 39.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 38.6 · SMA20: $63.86 · SMA50: $59.53
HTFL NASDAQ Head-to-Head Winner
Heartflow, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$46.69
+4.62% 1D
Market Cap $3.9B
TTM Revenue $239M
Forward P/E N/M
Beta / 30D Vol 1.29β · 89% Vol
Unified Composite Score
64.2 / 100 BUY
Tech 65.0 Fund 61.0 Flow 65.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.2 · SMA20: $53.72 · SMA50: $51.76

6-Pillar Scorecard Institutional Category Breakdown (ANDG 0 – 5 HTFL)

Columns: Metric · ANDG · HTFL
1. Valuation Multiples HTFL
Forward P/E N/M N/M
Trailing P/E N/M 66.6x
PEG Ratio N/M N/M
EV / Revenue N/M 16.4x
2. Growth & Scale HTFL
Revenue Growth (YoY) N/A +57.4%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $239M
Market Cap N/A $3.9B
3. Profitability & Quality HTFL
Gross Margin N/A 81.8%
Operating Margin N/A -30.0%
Net Profit Margin N/A -33.1%
Return on Equity (ROE) N/A -29.4%
4. Balance Sheet & Cash Flow HTFL
Cash Generation (TTM) N/A -$56M
Cash Flow Margin N/A -23.5%
Net Cash / Leverage N/A ROE $5.7M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HTFL
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 78.8% (35th %ile)
Put/Call OI Skew N/A 4.79x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ANDG (2) vs HTFL (7)
Institutional Metric ANDG HTFL Criterion Row Edge
Market Capitalization
Scale
N/A $3.9B Larger Scale HTFL
Trailing P/E Ratio
Valuation
N/M 66.6x Lower Multiple HTFL
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +57.4% Higher Growth HTFL
Operating Margin (TTM)
Profitability
N/A -30.0% Higher Margin HTFL
Net Profit Margin
Profitability
N/A -33.1% Higher Margin HTFL
Return on Equity (ROE)
Capital Efficiency
N/A -29.4% Higher ROE HTFL
52-Week Range Position
Momentum
79% ($18–$68) 66% ($20–$61) Stronger Trend ANDG
Beta / 30D Volatility
Risk Regime
0.45β · 44% Vol 1.29β · 89% Vol Lower Realized Risk ANDG
Unified Institutional Score
Composite Signal
56.7 / 100 (HOLD) 64.2 / 100 (BUY) Higher Composite HTFL
Trailing 12M Revenue (USD)
Operating Scale
N/A $239M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 81.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 16.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$56M ($5.7M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ANDG +6.82 pp
ANDG: -8.95% · HTFL: -15.77%
3M Horizon ANDG +22.71 pp
ANDG: +15.72% · HTFL: -6.99%
6M Horizon HTFL +8.14 pp
ANDG: +50.18% · HTFL: +58.32%
1Y Horizon ANDG +84.13 pp
ANDG: +161.59% · HTFL: +77.46%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANDG vs HTFL. Trailing 12-month operating profitability (ANDG N/A vs HTFL -30.0%) and valuation multiples (ANDG N/M vs HTFL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ANDG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HTFL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$239M
Gross Margin81.8%
Op. Margin-30.0%
ROE / Fwd P/E-29.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ANDG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ANDG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HTFL CONSOLIDATION
20d in phase · OBV NEUTRAL
Current IV 78.8%
IV Percentile 35th %ile
Put/Call OI Skew 4.79x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact HTFL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $46.86 · IV 74.2%

HTFL Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($4,686)

Compare $4,686 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 74.2% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $45 / $55 Bull Call Spread

Buy 1x $45C · Sell 1x $55C · 32d

Net Entry $576 Debit
T+5d @ +5% Move +$52 (+9%)
Max Risk / Buffer $576 Capped
5d Edge & Liquidity 0.4x R:R · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $40P / $50-$55C Seagull

Sell 1x $40P · Buy 1x $50/$55C · 32d

Net Entry $67 Debit
T+5d @ +5% Move +$97 (+16.3% RoM)
Max Risk / Buffer -14.6% Put Cushion ($597 Mgn)
5d Edge & Liquidity 0.9x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ANDG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HTFL Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $3.9B market capitalization and -30.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ANDG vs HTFL Key Questions & Quantitative Answers

As of Nov 20, 2026, Heartflow, Inc. (HTFL) is the stronger overall head-to-head candidate over ANDG (ANDG) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ANDG carries a Unified Composite Score of 56.7/100 (HOLD) at $57.85 (N/M Forward P/E, N/A operating margin), whereas HTFL carries 64.2/100 (BUY) at $46.69 (N/M Forward P/E, -30.0% operating margin). Technically, ANDG sits in a Neutral phase (RSI 38.6, UNCLASSIFIED options structure) and HTFL sits in a Neutral phase (RSI 41.2, CONSOLIDATION options structure).

HTFL leads the Growth & Scale pillar: ANDG posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HTFL at +57.4% YoY revenue growth and +0.0% YoY earnings growth on $239M TTM revenue (81.8% gross margin, -30.0% operating margin). On trailing 12-month operating scale, ANDG generates N/A in USD-normalized revenue versus $239M for HTFL. In operating R&D and SG&A reinvestment, ANDG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HTFL.

HTFL screens cheaper on headline valuation multiples. ANDG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HTFL trades at N/M Forward P/E, 66.6x Trailing P/E, N/M PEG, and 16.4x EV/Revenue (-23.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ANDG (N/A ROE) versus HTFL (-29.4% ROE) capital efficiency.

In options market volatility and institutional positioning, ANDG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 44% Vol realized risk). By comparison, HTFL carries 78.8% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 4.79x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.29β · 89% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.